Abstract

The receptor tyrosine kinase family of fibroblast growth factor receptors (FGFRs) play crucial roles in embryonic development, metabolism, tissue homeostasis and wound repair via stimulation of intracellular signalling cascades. As a consequence of FGFRs’ influence on cell growth, proliferation and differentiation, FGFR signalling is frequently dysregulated in a host of human cancers, variously by means of overexpression, somatic point mutations and gene fusion events. Dysregulation of FGFRs is also the underlying cause of many developmental dysplasias such as hypochondroplasia and achondroplasia. Accordingly, FGFRs are attractive pharmaceutical targets, and multiple clinical trials are in progress for the treatment of various FGFR aberrations. To effectively target dysregulated receptors, a structural and mechanistic understanding of FGFR activation and regulation is required. Here, we review some of the key research findings from the last couple of decades and summarise the strategies being explored for therapeutic intervention.

Highlights

  • Through their role in signal transduction pathways, protein kinases mediate a plethora of cellular phenotypic changes such as cell growth, proliferation, differentiation and survival [1]

  • Here we focus on FGFR3 aberrations, though in many instances corresponding mutations can be found in fibroblast growth factor receptor (FGFR) 1, 2 and 4

  • It has been established that FGFRs play crucial roles in a host of physiological processes which when dysregulated result in a plethora of pathologies

Read more

Summary

Introduction

Through their role in signal transduction pathways, protein kinases mediate a plethora of cellular phenotypic changes such as cell growth, proliferation, differentiation and survival [1]. An allosteric activation model featuring ligand-induced conformational change could be more appropriate for FGFRs (Figure 1), similar to that of insulin receptor tyrosine kinase [38].

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.